147 related articles for article (PubMed ID: 7915483)
1. Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis.
Bacharach-Buhles M; Pawlak FM; Matthes U; Joshi RK; Altmeyer P
Acta Derm Venereol Suppl (Stockh); 1994; 186():79-82. PubMed ID: 7915483
[TBL] [Abstract][Full Text] [Related]
2. Fumaric acid esters in the management of severe psoriasis.
Brewer L; Rogers S
Clin Exp Dermatol; 2007 May; 32(3):246-9. PubMed ID: 17362235
[TBL] [Abstract][Full Text] [Related]
3. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
4. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with fumaric acid esters in an 11-year-old male child with psoriasis.
Gerdes S; Domm S; Mrowietz U
Dermatology; 2011; 222(3):198-200. PubMed ID: 21502753
[TBL] [Abstract][Full Text] [Related]
6. Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy.
Salgo R; Thaçi D; Boehncke S; Diehl S; Hofmann M; Boehncke WH
Exp Dermatol; 2011 Feb; 20(2):130-3. PubMed ID: 21255092
[TBL] [Abstract][Full Text] [Related]
7. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
8. Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.
Sondermann W; Rompoti N; Leister L; Huptas L; Klode J; Dissemond J; Körber A
Dermatology; 2017; 233(4):295-302. PubMed ID: 28954274
[TBL] [Abstract][Full Text] [Related]
9. Fumaric acid esters.
Rostami Yazdi M; Mrowietz U
Clin Dermatol; 2008; 26(5):522-6. PubMed ID: 18755371
[TBL] [Abstract][Full Text] [Related]
10. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
[TBL] [Abstract][Full Text] [Related]
11. Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Wilsmann-Theis D; Frambach Y; Philipp S; Weyergraf AJ; Jacobi A; Mössner R; Gerdes S
Dermatology; 2015; 230(2):119-27. PubMed ID: 25661583
[TBL] [Abstract][Full Text] [Related]
12. Nail psoriasis improvement in a patient treated with fumaric acid esters.
Vlachou C; Berth-Jones J
J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
[TBL] [Abstract][Full Text] [Related]
13. Fumaric acid esters in psoriasis and multiple sclerosis.
Zecca C; Caporro M; Adami M; Mainetti C; Gobbi C
Clin Exp Dermatol; 2014 Jun; 39(4):488-91. PubMed ID: 24779791
[TBL] [Abstract][Full Text] [Related]
14. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.
Kokelj F; Plozzer C; Avian A; Trevisan G
Acta Dermatovenerol Croat; 2009; 17(3):170-5. PubMed ID: 19818215
[TBL] [Abstract][Full Text] [Related]
15. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
16. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
17. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
18. Immunological changes in psoriasis patients under long-term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?
Philipp S; Kokolakis G; Hund M; Witte E; Witte K; Kunz S; Roewert HJ; Sterry W; Sabat R
Eur J Dermatol; 2013; 23(3):339-43. PubMed ID: 23774790
[TBL] [Abstract][Full Text] [Related]
19. Natural killer and natural killer-T cells in psoriasis.
Cameron AL; Kirby B; Fei W; Griffiths CE
Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
[TBL] [Abstract][Full Text] [Related]
20. [Psoriasis therapy with fumaric acid and fumaric acid esters].
Raab W
Z Hautkr; 1984 May; 59(10):671-9. PubMed ID: 6741206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
